Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation.
- 1 September 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 11 (5), 1209-1222
- https://doi.org/10.1161/01.atv.11.5.1209
Abstract
In this study we assessed whether low density lipoproteins (LDL) isolated from minced aortic atherosclerotic plaques obtained at autopsy (A-LDL) shared structural and functional properties with LDL oxidized by incubation with Cu2+ for 8-18 hours at 20 degrees C (Ox-LDL). Although both A-LDL and Ox-LDL represented monomeric particles about the size of LDL, both differed from LDL in that they showed an increase in electrophoretic mobility relative to LDL, an increase in cholesterol to protein ratio, and an increase in reactivity with a monoclonal antibody that recognizes epitopes on malondialdehyde (MDA)-modified proteins. In addition, both showed an increase in fluorescence at 360 nm excitation, 430 nm emission, an increase in fragmentation of apolipoprotein B with patterns that were quite similar, and an increase in recognition by the scavenger receptor on mouse peritoneal macrophages (MPMs) based on competition of 125I-A-LDL and 125I-Ox-LDL degradation by excess acetylated LDL. In addition, inhibition of degradation by MPMs of 125I-A-LDL and 125I-Ox-LDL by excess unlabeled Ox-LDL and A-LDL were similar. When MDA was added in increasing amounts to labeled LDL and A-LDL, less MDA was required to modify A-LDL than LDl to obtain ligands that were degraded by MPMs to the same degree. Finally, both A-LDL and Ox-LDL but not LDL underwent aggregation (increased metastability) when concentrated to levels exceeding 1 mg protein/ml and showed enhanced macrophage uptake via phagocytosis (inhibition by cytochalasin D). These results demonstrate that A-LDL and Ox-LDL share properties additional to those previously reported, suggesting that oxidation may be a major mode of modification of LDL accumulating in atherosclerotic lesions. This could lead to lipid loading of macrophages induced by phagocytosis of aggregated particles, in addition to unregulated uptake via the scavenger receptor of monomeric particles.Keywords
This publication has 37 references indexed in Scilit:
- Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteinsBiochemical and Biophysical Research Communications, 1989
- Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenalBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Isolation, purification, and characterization of a lipoprotein containing apo B from the human aortaAtherosclerosis, 1982
- Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Apo B concentration in the normal human aortaBiochemical and Biophysical Research Communications, 1978
- Enzymatische Bestimmung des Gesamt-Cholesterins im Serumcclm, 1974
- Interaction of phosphatidylcholine and apolipoprotein-alanine: electron microscopic studiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973
- RELATIONSHIP BETWEEN LOW-DENSITY LIPOPROTEIN IN AORTIC INTIMA AND SERUM-LIPID LEVELSThe Lancet, 1972
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970